Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.
Nacev BA, Dabas Y, Paul MR, Pacheco C, Mitchener M, Perez Y, Fang Y, Soshnev AA, Barrows D, Carroll T, Socci ND, St Jean SC, Tiwari S, Gruss MJ, Monette S, Tap WD, Garcia BA, Muir T, Allis CD. Nacev BA, et al. Among authors: tap wd. Nat Commun. 2024 Oct 22;15(1):9103. doi: 10.1038/s41467-024-53502-z. Nat Commun. 2024. PMID: 39438498 Free PMC article. No abstract available.
Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.
Nacev BA, Dabas Y, Paul MR, Pacheco C, Mitchener M, Perez Y, Fang Y, Soshnev AA, Barrows D, Carroll T, Socci ND, St Jean SC, Tiwari S, Gruss MJ, Monette S, Tap WD, Garcia BA, Muir T, Allis CD. Nacev BA, et al. Among authors: tap wd. Nat Commun. 2024 Jun 17;15(1):5155. doi: 10.1038/s41467-024-49486-5. Nat Commun. 2024. PMID: 38886411 Free PMC article.
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.
D'Angelo SP, Druta M, Van Tine BA, Liebner D, Schuetze SM, Tap WD, Preston J, Goodison S, D'Souza JW, Kapoor GS, Suchindran S, Zajic S, Bhaskar A, Kaczynski H, Kim J, Klohe E, Corigliano E, Eleftheriadou I, Nathenson MJ, Somaiah N. D'Angelo SP, et al. Among authors: tap wd. J Clin Oncol. 2025 Jan 21:JCO2401466. doi: 10.1200/JCO-24-01466. Online ahead of print. J Clin Oncol. 2025. PMID: 39836945
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.
Desai J, Wagner AJ, Carrasco Garcia I, Cesari M, Gordon M, Lin CC, Papai Z, Ryan CW, Tap WD, Trent JC, Gelderblom H, Grimison P, López Pousa A, Van Tine BA, Rubinacci M, Dai D, Rajper AW, Tecson K, Wooddell M, Stacchiotti S. Desai J, et al. Among authors: tap wd. Cancer. 2025 Jan 1;131(1):e35634. doi: 10.1002/cncr.35634. Epub 2024 Nov 12. Cancer. 2025. PMID: 39533157 Free PMC article. Clinical Trial.
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP. Movva S, et al. Among authors: tap wd. Clin Cancer Res. 2024 Dec 16;30(24):5612-5619. doi: 10.1158/1078-0432.CCR-24-2519. Clin Cancer Res. 2024. PMID: 39405335
209 results